Second Sight Medical Products Inc. Daily Stock Analysis

Daily Stock Analysis, EYES, Second Sight Medical Products Inc, priceseries

Second Sight Medical Products Inc. Daily Stock Analysis
Stock Information
Open
1.24
Close
1.23
High
1.26
Low
1.20
Previous Close
1.23
Daily Price Gain
0.00
YTD High
1.85
YTD High Date
Jan 3, 2022
YTD Low
1.14
YTD Low Date
Feb 24, 2022
YTD Price Change
-0.60
YTD Gain
-32.79%
52 Week High
20.00
52 Week High Date
Mar 9, 2021
52 Week Low
1.14
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-10.54
52 Week Gain
-89.55%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 1. 2017
10.88
Dec 19. 2017
14.37
12 Trading Days
32.06%
Link
LONG
Feb 2. 2018
16.40
Feb 6. 2018
17.24
2 Trading Days
5.12%
Link
LONG
May 14. 2018
15.60
May 29. 2018
16.78
10 Trading Days
7.56%
Link
LONG
Apr 5. 2019
6.84
Apr 17. 2019
8.06
8 Trading Days
17.86%
Link
LONG
Jul 15. 2019
6.46
Jul 25. 2019
6.87
8 Trading Days
6.26%
Link
LONG
Aug 30. 2019
6.24
Sep 23. 2019
6.81
15 Trading Days
9.10%
Link
LONG
Nov 6. 2019
6.80
Nov 7. 2019
7.20
1 Trading Days
5.88%
Link
LONG
Jan 28. 2020
4.81
Feb 3. 2020
5.12
4 Trading Days
6.44%
Link
LONG
Apr 17. 2020
1.67
Apr 22. 2020
1.77
3 Trading Days
5.95%
Link
LONG
Jun 3. 2020
1.02
Jun 10. 2020
1.16
5 Trading Days
13.73%
Link
LONG
Nov 24. 2020
0.87
Dec 28. 2020
2.19
22 Trading Days
151.55%
Link
LONG
Jan 22. 2021
1.94
Jan 29. 2021
2.05
5 Trading Days
5.67%
Link
LONG
Feb 3. 2021
2.14
Feb 17. 2021
2.41
9 Trading Days
12.77%
Link
LONG
Mar 5. 2021
5.79
Mar 22. 2021
12.71
11 Trading Days
119.54%
Link
LONG
Jun 3. 2021
5.57
Jun 9. 2021
5.93
4 Trading Days
6.42%
Link
Company Information
Stock Symbol
EYES
Exchange
NasdaqCM
Company URL
http://www.2-sight.com
Company Phone
818-833-5000
CEO
Jonathan Will McGuire
Headquarters
California
Business Address
12744 SAN FERNANDO ROAD, BLDG. 3, SYLMAR, CA 91342
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001266806
About

Second Sight Medical Products, Inc. creates a retinal prosthesis to provide sight to patients blinded from outer retinal degenerations such as Retinitis Pigmentosa. It manufactures and market implantable visual prosthetics to enable blind individuals to overcome disability and achieve greater independence. The company was founded by Alfred E. Mann, Aaron Mendelsohn, Dr. Sam Williams, Robert J. Greenberg, and Gunnar Bjorg in 1998 and is headquartered in Sylmar, CA.

Description

Second Sight Medical Products, Inc. develops, manufactures, and markets prosthetic devices to restore functional vision to blind individuals in the United States, Italy, Germany, France, and Canada. The company's product is the Argus II System, which treats outer retinal degenerations, such as retinitis pigmentosa. The company was formerly known as Second Sight LLC. and changed its name to Second Sight Medical Products, Inc. Second Sight Medical Products, Inc. was founded in 1998 and is headquartered in Sylmar, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading